These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mithramycin selectively inhibits the transcriptional activity of a transfected human c-myc gene. Ray R, Thomas S, Miller DM. Am J Med Sci; 1990 Oct; 300(4):203-8. PubMed ID: 2147360 [Abstract] [Full Text] [Related]
6. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, Miller DM. J Clin Invest; 1991 Nov; 88(5):1613-21. PubMed ID: 1834700 [Abstract] [Full Text] [Related]
7. Modulation of DNA-protein interactions in the P1 and P2 c-myc promoters by two intercalating drugs. Vaquero A, Portugal J. Eur J Biochem; 1998 Jan 15; 251(1-2):435-42. PubMed ID: 9492315 [Abstract] [Full Text] [Related]
10. Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target. Remsing LL, Bahadori HR, Carbone GM, McGuffie EM, Catapano CV, Rohr J. Biochemistry; 2003 Jul 15; 42(27):8313-24. PubMed ID: 12846580 [Abstract] [Full Text] [Related]
11. Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters. DesJardins E, Hay N. Mol Cell Biol; 1993 Sep 15; 13(9):5710-24. PubMed ID: 8355712 [Abstract] [Full Text] [Related]
15. The c-myc promoter binding protein (MBP-1) and TBP bind simultaneously in the minor groove of the c-myc P2 promoter. Chaudhary D, Miller DM. Biochemistry; 1995 Mar 14; 34(10):3438-45. PubMed ID: 7880838 [Abstract] [Full Text] [Related]
17. Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Thalmeier K, Synovzik H, Mertz R, Winnacker EL, Lipp M. Genes Dev; 1989 Apr 14; 3(4):527-36. PubMed ID: 2721961 [Abstract] [Full Text] [Related]
20. Effects of IL-3 on promoter usage, attenuation and antisense transcription of the c-myc oncogene in the IL-3-dependent Ba/F3 early pre-B cell line. Chang Y, Spicer DB, Sonenshein GE. Oncogene; 1991 Nov 14; 6(11):1979-82. PubMed ID: 1682864 [Abstract] [Full Text] [Related] Page: [Next] [New Search]